The presentation brings together over 55 years of research showing that
omega-3 levels in cell membranes strongly predict health outcomes across all populations. An inflammatory index based on the omega-6 to omega-3 ratio correlates with rising disease risk regardless of age, BMI, smoking status, or existing illness. Most people test severely deficient, often above
20:1, placing them in an exponential risk zone.
Omega-3 is not optional biology.
EPA and DHA regulate inflammation, immune signaling, and membrane function. Plant sources provide only
ALA, which rarely converts into EPA and DHA due to enzyme competition from excessive omega-6 intake. This creates a
self-reinforcing inflammatory loop where inflammation never fully switches off.
A major focus is mitochondrial health. Omega-3 is essential for
cardiolipin, a lipid required for mitochondrial energy production. Without adequate omega-3, ATP output drops and cells lose aerobic efficiency, directly affecting the heart, brain, liver, and other high-energy tissues.
The talk challenges conventional lipid testing. Reaching an omega-3 index above 8% consistently aligns with lower cardiovascular events and mortality, while cholesterol shows no meaningful causal relationship. The core message is simple: test omega-3 status, correct the imbalance, and address disease at the membrane and mitochondrial level, not through secondary markers.